C R Madden studies how changes in metabolism during early life can protect against the development of neurodegenerative diseases later in life. Specifically, their research examines how exposing young organisms, like worms, to mild stress can lead to significant changes in how cells use energy, particularly fat. This metabolic shift is important because it helps prevent the accumulation of amyloid proteins, which are often linked to diseases like Alzheimer's. By understanding these mechanisms, their work opens up possibilities for developing new strategies to combat age-related neurodegenerative conditions.
Key findings
Exposure to mild stress during development led to changes in fat metabolism that produced lasting protective effects against amyloid toxicity in older worms.
The protein HSF-1 played a critical role in rewiring the metabolism of these worms, allowing them to burn fat more efficiently and resist amyloid damage.
The protective effect against amyloid accumulation persisted into old age, demonstrating the long-term benefits of early life metabolic changes.
Frequently asked questions
Does Dr. C R Madden study Alzheimer's disease?
Yes, Dr. Madden's research focuses on mechanisms that prevent the buildup of amyloid proteins, which are known to be harmful in Alzheimer's.
What is the significance of early life stress in Dr. Madden's research?
Early life stress can trigger beneficial metabolic changes that protect against age-related diseases, highlighting its importance in development.
How does Dr. Madden's work relate to aging?
Dr. Madden investigates how early metabolic changes can have protective effects that help combat the impacts of aging on the brain, particularly concerning neurodegenerative diseases.
Publications in plain English
Early life changes in histone landscape protect against age-associated amyloid toxicities through HSF-1-dependent regulation of lipid metabolism.
2024
Nature aging
Oleson BJ, Bhattrai J, Zalubas SL, Kravchenko TR, Ji Y +7 more
Plain English Researchers found that exposing worms to mild stress early in life reprograms how their cells manage fats and energy, which protects them from harmful protein clumps that accumulate with age. This protection works through a protein called HSF-1 that gets activated during development and permanently changes how the worms' cells burn fat for energy. The discovery shows that surviving stress in youth creates a metabolic shield against brain diseases like Alzheimer's that involve toxic protein buildup.
Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon.
2011
Journal of virology
Kumar M, Jung SY, Hodgson AJ, Madden CR, Qin J +1 more
Plain English This study looked at how a protein from the Hepatitis B virus (HBV) called HBx interacts with a protein in the body named IPS-1, which is important for activating the immune response. The researchers found that HBx can block the activation of a key immune signal called beta interferon, which normally helps fight off viral infections. Specifically, they observed that HBx reduces this immune response in cells, particularly when it comes to signals triggered by double-stranded DNA, but not when triggered by another substance.
Who this helps: This research helps patients with Hepatitis B by providing insights into how the virus evades the immune system, which could lead to better treatments.
Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice.
2009
Virology
Keasler VV, Hodgson AJ, Madden CR, Slagle BL
Plain English This study focused on understanding how a specific protein (HBx) from the hepatitis B virus affects its replication. Researchers discovered that when the HBx protein is located in the nucleus of liver cells, it can successfully help the virus replicate, while another version of the protein that doesn't stay in the nucleus cannot. This is important because it reveals a crucial aspect of how hepatitis B virus works, which could lead to better treatments for the virus.
Who this helps: Patients with hepatitis B.
Fine-needle aspiration biopsy of chondromyxoid fibroma: an investigation of four cases.
2009
American journal of clinical pathology
Bergman S, Madden CR, Geisinger KR
Plain English This study looked at a rare bone tumor called chondromyxoid fibroma in four patients who had fine-needle aspiration biopsies to obtain samples. The researchers found that a key indicator for diagnosing this tumor was the presence of specific cell fragments in all four cases, along with some abnormal cell nuclei in moderate amounts. Most samples were not very cell-rich, but in one case, the sample showed many giant cells, supporting the diagnosis. This research is important because it helps doctors better identify chondromyxoid fibroma early on using less invasive testing methods.
Who this helps: This helps patients by improving early diagnosis and treatment options for their condition.
Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo.
2007
Journal of virology
Keasler VV, Hodgson AJ, Madden CR, Slagle BL
Plain English This study focused on a protein called HBx found in the hepatitis B virus (HBV) and examined its role in helping the virus replicate in lab cells and mice. Researchers found that when they removed HBx, virus replication dropped by 65% in lab cells and by up to 83% in the livers of mice. This is important because it shows that HBx is crucial for the virus to reproduce, which could lead to better treatments for the disease.
Who this helps: This helps patients with hepatitis B and doctors treating them.
Aneurysmal bone cyst: fine-needle aspiration findings in 23 patients with clinical and radiologic correlation.
2007
American journal of clinical pathology
Creager AJ, Madden CR, Bergman S, Geisinger KR
Plain English This study looked at 23 patients with aneurysmal bone cysts (ABC) and evaluated the results from a procedure called fine-needle aspiration biopsy (FNAB). The analysis showed that FNAB accurately identified ABC in 82% of cases when excluding those with insufficient samples, although in some cases, it couldn't definitively diagnose the condition. This information is important because while FNAB can be useful, doctors should rely on a combination of clinical signs and imaging to make a more accurate diagnosis.
Who this helps: This helps doctors in diagnosing bone tumors more accurately.
Plain English This study looked at mice genetically modified to express both the hepatitis C virus (HCV) and the hepatitis B virus X protein (HBx) to see if HBx makes liver damage from HCV worse. They found that 21% of the mice with both HCV and HBx developed liver cancer by the age of 16 months, while none of the mice with only HCV did. Additionally, at eight months old, the mice with both viruses had more severe fat buildup in the liver and showed more signs of liver cell growth, indicating that HBx worsens liver damage by disrupting normal cell death and regeneration.
Who this helps: This research helps patients with hepatitis C by improving understanding of the disease's progression and potential treatments.
Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS
Plain English This study looked at the presence of simian virus 40 (SV40) in various human cancers, specifically brain tumors, bone cancers, malignant mesothelioma, and non-Hodgkin's lymphoma. It found that brain tumor samples were nearly four times more likely to show SV40 than control samples, while the association was even stronger for mesothelioma (17 times more likely) and bone cancer (25 times more likely). These findings highlight a significant link between SV40 and certain types of cancer, suggesting further research is needed to understand the current prevalence of this virus and its potential role in cancer.
Who this helps: This helps researchers and healthcare providers working on cancer prevention and treatment.
Enhancement of hepatitis B virus replication by its X protein in transgenic mice.
2002
Journal of virology
Xu Z, Yen TS, Wu L, Madden CR, Tan W +2 more
Plain English This study looked at how the X protein of the hepatitis B virus (HBV) affects the virus's ability to replicate in specially designed mice. The researchers found that while the X protein isn't necessary for the virus to replicate, it does boost replication significantly by activating genes related to the virus—showing a key role in the viral life cycle. Specifically, the presence of the X protein increased viral replication but precise numbers were not provided in the summary.
Who this helps: This research helps doctors and researchers working on treatments for hepatitis B virus.
Association between simian virus 40 and non-Hodgkin lymphoma.
2002
Lancet (London, England)
Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS +3 more
Plain English This research studied the link between simian virus 40 (SV40) and non-Hodgkin lymphoma, a type of cancer that has become more common, especially in people with HIV. The study found that SV40 was present in 42% of non-Hodgkin lymphoma cases among the analyzed patients, but not in any non-cancerous lymphoid or other cancer samples. This discovery is important because it suggests that SV40 may play a role in the development of certain non-Hodgkin lymphomas, adding to the list of cancers possibly linked to this virus.
Who this helps: Patients diagnosed with non-Hodgkin lymphoma.
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.
2002
Journal of virology
Madden CR, Finegold MJ, Slagle BL
Plain English This study looked at how a protein from the hepatitis B virus (HBV) affects the DNA of mice exposed to a harmful mold chemical called aflatoxin B1 (AFB1). The researchers found that the presence of this protein led to a 24% increase in overall DNA mutations and caused the specific type of mutation, G/C-to-T/A, to occur about twice as often after exposure to AFB1. These findings are important because they suggest that HBV infection might increase the risk of liver cancer when people are also exposed to toxic substances.
Who this helps: This helps patients with hepatitis B and related liver conditions.
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.
2001
Journal of virology
Madden CR, Finegold MJ, Slagle BL
Plain English This study looked at how the hepatitis B virus X protein (HBx) may promote liver cancer in mice exposed to a chemical that can cause tumors. The researchers found that mice with HBx had about twice as many liver lesions and showed a six- to eightfold increase in genetic mutations compared to normal mice after treatment, indicating a significant role for HBx in liver cell growth and changes. This matters because it helps explain how chronic hepatitis B infection can lead to liver cancer, which can ultimately improve prevention and treatment strategies.
Who this helps: This helps patients with chronic hepatitis B and doctors treating them.
Stimulation of cellular proliferation by hepatitis B virus X protein.
2001
Disease markers
Madden CR, Slagle BL
Plain English Researchers studied how a protein from the hepatitis B virus (HBV), called HBx, affects the growth of liver cells. They found that HBx can make these cells multiply more, both in lab tests and in living organisms. This increased cell growth could make the liver cells more vulnerable to other substances that cause cancer, contributing to the development of liver cancer in people with chronic HBV infections.
Who this helps: This research helps patients with chronic hepatitis B by improving understanding of how the virus may lead to liver cancer.
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice.
2000
Journal of virology
Madden CR, Finegold MJ, Slagle BL
Plain English This study looked at how the hepatitis B virus X protein (HBx) affects DNA repair and the mutation rate in special mice that have been genetically modified to express this protein. The researchers found that mice expressing HBx did not show a significant increase in mutations in their liver DNA compared to those without HBx, meaning that HBx doesn't seem to cause more genetic damage despite being linked to liver cancer. This finding is important because it helps clarify the role of HBx in cancer development and may lead to better understanding of how hepatitis B contributes to liver disease.
Who this helps: This helps researchers and doctors working on hepatitis B and liver cancer prevention and treatment.
Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus.
1996
Virology
Madden CR, Shih DS
Plain English This study focused on a strain of the equine infectious anemia virus (EIAV) and how changes in its genetic material, specifically the long terminal repeat (LTR) region, affect the virus's ability to replicate and cause disease in specific cell cultures from donkeys. The researchers found that the new strain had significant genetic mutations that allowed it to replicate over seven times more effectively than the earlier strain, although these changes did not make it more harmful to the cells. This is important because understanding how the virus replicates can help in developing better treatments for infections caused by EIAV.
Who this helps: This research helps veterinarians and researchers working on equine health.
The botryoid odontogenic cyst. Report of a case and review of the literature.
1985
Journal of periodontology
Lynch DP, Madden CR
Plain English Researchers looked at a type of dental cyst called the botryoid odontogenic cyst, which has unique features like a lobular appearance and specific cell types. They found that this cyst arises from certain tooth tissue remnants and has distinct characteristics that help in identifying it. Understanding these features is important because it helps doctors accurately diagnose and treat this rare cyst type.
Who this helps: This benefits dentists and oral surgeons dealing with cysts in patients.
Charles R Madden Betty L Slagle Amanda J Hodgson Victor V Keasler B L Slagle Simon Bergman Christopher R Madden Kim R Geisinger Milton J Finegold Regis A Vilchez
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.